Compounds > adamantane
Page last updated: 2024-08-21

adamantane and Granulocytic Leukemia, Chronic

adamantane has been researched along with Granulocytic Leukemia, Chronic in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, D; Bernthaler, T; Eisenwort, G; Entner, M; Hadzijusufovic, E; Herrmann, H; Hoermann, G; Rülicke, T; Sadovnik, I; Stefanzl, G; Valent, P; Willmann, M1
Darwiche, ND; El-Eit, RM; Hmadi, RA; Iskandarani, AN; Jabbour, MN; Mahon, FX; Nasr, RR; Pisano, CC; Zaatari, GS1
Adjei, AA; Bone, N; Bruzek, LM; Chandra, J; Hackbarth, J; Karp, JE; Kaufmann, SH; Kay, NE; Le, S; Loegering, D; Narayanan, VL; Sausville, EA; Tefferi, A1
Basic, I; Chandra, J; Giles, F; Golemovic, M; Kantarjian, H; Manshouri, T; Orsolic, N; Quintás-Cardama, A; Scappini, B; Verstovsek, S1
Brunetti, IL; Colturato, VA; da Fonseca, LM; de Mattos, ER; Falcão, RP; Kanegae, MP; Ximenes, VF1
Kaufmann, SH; Kaur, G; Kottke, TJ; Narayanan, VL; Sausville, EA; Svingen, PA; Tefferi, A1
Chandra, J; Griffin, JD; Hallgren, CG; Kaufmann, SH; Kottke, TJ; Litzow, MR; Mow, BM; Narayanan, VL; Sausville, EA; Svingen, PA; Tefferi, A; Weisberg, E1

Other Studies

7 other study(ies) available for adamantane and Granulocytic Leukemia, Chronic

ArticleYear
Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph
    Experimental hematology, 2018, Volume: 57

    Topics: Adamantane; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Coculture Techniques; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Fibroblasts; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Neoplasm Proteins; Nitriles; Protein Kinase Inhibitors; Pyrimidines; Pyrrolidines; Tumor Cells, Cultured; Vildagliptin; Xenograft Model Antitumor Assays

2018
ST1926, an orally active synthetic retinoid, induces apoptosis in chronic myeloid leukemia cells and prolongs survival in a murine model.
    International journal of cancer, 2015, Aug-01, Volume: 137, Issue:3

    Topics: Adamantane; Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cinnamates; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Enzyme Activation; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potential, Mitochondrial; Mice; Reactive Oxygen Species; Retinoids; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays

2015
Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells.
    Blood, 2003, Dec-15, Volume: 102, Issue:13

    Topics: Acetylcysteine; Adamantane; Antioxidants; Apoptosis; Buthionine Sulfoximine; DNA Damage; DNA, Neoplasm; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Glutathione; Humans; Hydroquinones; K562 Cells; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Neoplasm Proteins; Neoplastic Stem Cells; Quinones; Reactive Oxygen Species; Tumor Stem Cell Assay; Tyrphostins

2003
Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells.
    Cancer science, 2006, Volume: 97, Issue:9

    Topics: Adamantane; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Cells, Cultured; Drug Resistance, Neoplasm; Drug Synergism; Flow Cytometry; Humans; Hydroquinones; Imatinib Mesylate; Inhibitory Concentration 50; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Phosphorylation; Piperazines; Pyrimidines; Tyrosine

2006
Chemiluminescent determination of leukocyte alkaline phosphatase: an advantageous alternative to the cytochemical assay.
    Journal of clinical laboratory analysis, 2007, Volume: 21, Issue:2

    Topics: Adamantane; Alkaline Phosphatase; Histocytochemistry; Humans; Indicators and Reagents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemoid Reaction; Luminescence; Luminescent Measurements; Neutrophils

2007
Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:1

    Topics: Adamantane; Apoptosis; Caspase 9; Caspases; Cell Division; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Humans; Hydroquinones; K562 Cells; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Transfection; Tumor Stem Cell Assay; Tyrphostins

2000
Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro.
    Blood, 2002, Jan-15, Volume: 99, Issue:2

    Topics: Adamantane; Apoptosis; Benzamides; Caspase 9; Caspases; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Humans; Hydroquinones; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphorylation; Piperazines; Protein Biosynthesis; Protein Processing, Post-Translational; Proteins; Pyrimidines; Recombinant Fusion Proteins; Serpins; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay; Viral Proteins; X-Linked Inhibitor of Apoptosis Protein

2002